Open Inflammatory Bowel Disease (Crohn's / UC) in the Repurposing ExplorerInflammatory Bowel Disease (Crohn's / UC) hub
Mesalamine
Drug · tier A · 8 trials (1 recruiting) · 12 publications · score 76.0
Balsalazide
Drug · tier A · 7 trials (0 recruiting) · 13 publications · score 75.5
Infliximab
Drug · tier A · 8 trials (1 recruiting) · 15 publications · score 75.0
Adalimumab
Drug · tier A · 8 trials (0 recruiting) · 13 publications · score 74.0
Methotrexate
Drug · tier A · 8 trials (0 recruiting) · 18 publications · score 71.5
Curcumin
Drug · tier A · 8 trials (0 recruiting) · 14 publications · score 69.5
Sulfasalazine
Drug · tier A · 6 trials (0 recruiting) · 14 publications · score 67.5
Nicotine
Drug · tier A · 4 trials (0 recruiting) · 15 publications · score 62.5
Etanercept
Drug · tier A · 5 trials (0 recruiting) · 15 publications · score 60.0
Selenium
Drug · tier A · 5 trials (1 recruiting) · 9 publications · score 59.5
Balsalazide Disodium
Drug · tier A · 7 trials (0 recruiting) · 1 publications · score 47.5
Olsalazine Sodium
Drug · tier A · 1 trials (0 recruiting) · 4 publications · score 32.5
Indomethacin
Drug · tier A · 2 trials (0 recruiting) · 1 publications · score 27.5
Irinotecan Hydrochloride
Drug · tier A · 1 trials (0 recruiting) · 0 publications · score 24.5
Milk Thistle Seed Extract
Drug · tier A · 1 trials (1 recruiting) · 0 publications · score 24.0
Zileuton
Drug · tier A · 0 trials (0 recruiting) · 2 publications · score 24.0
Tazobactam
Drug · tier A · 1 trials (1 recruiting) · 0 publications · score 23.0
Research map, not treatment advice. Built 2026-10-07.